Abbott Laboratories (ABT)

ABT (NYSE:Health Services) EQUITY
$46.50
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | ABT Avg Daily Volume: 5,588,500
Last Update: 03/26/15 - 4:00 PM EDT
Volume: 0
YTD Performance: 3.29%
Open: $0.00
Previous Close: $46.50
52 Week Range: $36.65 - $47.88
Oustanding Shares: 1,508,977,828
Market Cap: 70,212,738,337
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 7 8
Moderate Buy 4 4 4 4
Hold 5 5 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.75 1.79 1.91 1.79
Latest Dividend: 0.24
Latest Dividend Yield: 2.06%
Dividend Ex-Date: 04/13/15
Price Earnings Ratio: 41.54
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
41.54 31.20 27.33
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.42% 20.59% 52.48%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.30 -0.48 -0.19
Net Income -11.30 -0.64 -0.28
EPS -8.00 -0.50 -0.21
Earnings for ABT:
EBITDA 4.15B
Revenue 20.25B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.42 $0.52 $2.15 $2.42
Number of Analysts 10 9 15 14
High Estimate $0.43 $0.54 $2.20 $2.64
Low Estimate $0.40 $0.51 $2.11 $2.35
Prior Year $0.41 $0.54 $2.28 $2.15
Growth Rate (Year over Year) 1.71% -3.29% -5.64% 12.59%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
I really like a couple of names despite the uncertainty.
The logic of owning the pure play is attractive.
Bullish
Jan 30, 2015 | 7:09 AM EST
ABT was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $52 price target. Company can deliver strong revenue growth a...
Bearish
Jan 13, 2015 | 7:18 AM EST
ABT was downgraded from Buy to Hold, Jefferies said. $50 price target. Valuation call, as the company lacks near-term visibility.  ...
It's worth looking at the dividend payers this time of year.

Merger Mania Benefits Mylan Real Money Pro($)

Whether it's acquiring or the acquired, Mylan is building shareholder value.
Bullish
Oct 29, 2014 | 6:31 AM EDT
ABT was upgraded to Buy, Deutsche Bank said. $54 price target. Management has the company poised to deliver sustained growth. 
There may be a wave of consolidation.
And don't try to catch every move.
Bearish
Jul 21, 2014 | 7:59 AM EDT
ABT 2015E-2018E EPS estimates lowered 7-10%, Jefferies said. Buy rating. Estimates reflect the divestiture of the developed market EPD ...

Columnist Conversations

Tastes - be it for clothes, foods, whatever - tend to shift over time. How many restaurant concepts have blown...
Buffett said he didn't care about healthier foods he cared about brands. My view is that brands get old and ou...
I am just learning how to properly utilize the app. I broadcast a tour through my Seeabreeze offices in Palm B...
Good piece today on PEP and GM, but what about those companies that are being hit, like Hershey (HSY) or McDon...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.